Dr. C. Thomas Caskey

• 
  www.theadvisorygroup.com/index.php?page=c-thomas-caskey - [Cached Version]
  Published on: 9/15/2008    Last Visited: 9/15/2008  

  C. Thomas Caskey, M.D.,Washington Advisory Group - C. Thomas Caskey, M.D.
  ...
  C. Thomas Caskey, M.D.
  
  Director EmeritusThe Washington Advisory Group, an LECG Company
  
  C. Thomas Caskey advises on biotechnology and biomedical projects.Dr. Caskey is Director and CEO-Elect The Brown Foundation Institute of Molecular Medicine as well as Executive Vice President for Molecular & Genetics of the University of Texas Health Science Center at Houston.He served as Chief Executive Officer and President of Cogene Ventures.
  
  Dr. Caskey was Senior Vice President, Research at Merck Research Laboratories from 1994 to 2000 and Trustee and President of the Merck Genome Research Institute from 1999 to 2000.At the Genome Research Institute, he expanded gene function research and the dissemination of genetic technology in the biomedical community, an effort he began as President of the Human Genome Organization from 1993 to 1996.
  
  He has served Baylor College of Medicine for nearly 30 years in several senior positions, including as Chairman of the Department of Molecular and Human Genetics, where he continues to be an adjunct professor.
  
  Dr. Caskey has been awarded numerous academic and industry-related honors for his work in human genetics.Dr. Caskey received the Distinguished Texas Geneticist Award.Dr. Caskey serves on several national research review panels, including the Intramural Human Genome Projects Special Review Committee at the National Institutes of Health and on the editorial boards of the Journal of the American Medical Association and Science.
  
  He is a member of the Institute of Medicine and the National Academy of Sciences.He also serves on the boards of several corporations, including Lexicon, MDS, En Vivo, Odyssey and Argolyn.Dr. Caskey is Associate Director of the Essex Woodlands Fund and serves on the Committee of 17 for Texas Governor Perry, which has oversight for an Emerging Technology Fund.
  
  Dr. Caskey earned his medical doctorate from Duke University and is Board certified in Internal Medicine, Clinical Genetics, Metabolic Diseases, and Molecular Diagnostics.

• 
  www.paxilprogress.org/forums/journal.php?s=1f775ce4e30a - [Cached Version]
  Published on: 4/6/2006    Last Visited: 10/27/2007  

  Dr. C. Thomas Caskey, a former Merck senior vice president for drug development, including Gardasil, said he hoped the FDA does not focus on sexual politics.
  
  "I hope it's more a discussion of how do you introduce a preventive vaccine," he said."In this case, a parent is making a selection for a late onset adult disease.
  ...
  Dr. C. Thomas Caskey of Houston is president and CEO of Cogene Biotech Ventures.He also serves as president of the Academy of Medicine, Engineering and Science of Texas.Caskey has served as senior vice president of Human Genetics and Vaccines Discovery at Merck Research Laboratories, and president of Merck Genome Research Institute.Caskey serves as an adjunct professor in the department of molecular and human genetics at Baylor College of Medicine and is a distinguished professor at the Institute of Molecular Medicine at University of Texas Medical Center in Houston.

• 
  www.tamest.org/conference06presentations/caskeyvideo.ht - [Cached Version]
  Published on: 3/31/2006    Last Visited: 6/28/2007  

  Dr. C. Thomas CaskeyTAMEST Past President
  
  DirectorInstitute of Molecular Medicine

• 
  houston.bizjournals.com/houston/stories/2005/08/22/dail - [Cached Version]
  Published on: 8/22/2005    Last Visited: 4/10/2007  

  Cogene BioTech Ventures, Mincron Software Systems, Rick Perry, Dr. C. Thomas Caskey, Walter Ulrich,
  ...
  Cogene Biotech Ventures President and CEO Dr. C. Thomas Caskey and Walter Ulrich, CEO of Mincron Software Systems, were among the 17 high-tech leaders, entrepreneurs and research experts named to the advisory committee last Friday.
  ...
  In addition to his role at Cogene, Caskey serves as president of the Academy of Medicine, Engineering and Science of Texas.He has served as senior vice president of Human Genetics and Vaccines Discovery at Merck Research Laboratories and as president of Merck Genome Research Institute.
  
  Caskey also serves as an adjunct professor in the department of molecular and human genetics at Baylor College of Medicine and is a distinguished professor at the Institute of Molecular Medicine at University of Texas Medical Center in Houston.

• 
  www.tri-conference.com/speaker_bios/c_thomas_caskey.asp - [Cached Version]
  Published on: 10/6/2008    Last Visited: 5/11/2008  

  Dr. Caskey attended the University of South Carolina (1956-58) and Duke University Medical School (1958-63).As a medical student he was a Biochemical Fellow
  ...
  his M.D. degree, Dr. Caskey remained at Duke as an intern and resident in the Department of Medicine (1963-65).His first resarch paper with Dr. H. Estes was on the "ST segment of the EKG in myocardial injury".
  
  Dr. Caskey then went to the National Institutes of Health (1965-71) where he was a Research Associate with Nobel Laureate Marshall Nirenberg.His research with Dr. Nirenberg proved the universality of the genetic code for living organisms on earth.Dr. Caskey then became Senior Investigator in the Laboratory of Biochemical Genetics (1967-70) and Head of the Section of Medical Genetics at NHLBI (1970-71).As an independent investigator he discovered the mechanism of code punctuation (stop) to be translated by proteins, not tRNA.
  
  Dr. Caskey joined Baylor College of Medicine in 1971 where he served as Chief of the Section of Medical Genetics (1971-85) and Professor of Medicine and Biochemistry (1971-94).He discovered 11 genetic disease genes during this period.From 1976 to 1994 Dr. Caskey was a Howard Hughes Medical Institute Investigator.Most importantly, he
  ...
  sabbatical leave (1979-80) Dr. Caskey was a Faculty Scholar at the
  ...
  Dr. Caskey left academia in 1994 to assume the position of Senior Vice President for Research at Merck Research Laboratories, West Point, Pennsylvania, and Trustee and President of the Merck Genome Research Institute.The development of the adenoviral vector HIV vaccine was achieved by a research team under Dr. Caskey's direction.
  
  Dr. Caskey returned to Houston in 2000 and became Founding Director and Chief Executive Officer of Cogene Biotech Ventures and Cogene Ventures, venture capital funds designed to support early-stage biotechnology and life sciences companies using genome technology for drug discovery.
  
  In 2006 Dr. Caskey was appointed Chief Operating Officer and Director-/CEO-Elect of the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases and Executive Vice President of Molecular Medicine and Genetics at the University of Texas Health Science Center-Houston. In 2007 Dr. Caskey was named Director and Chief Executive Officer of the Brown Foundation Institute of Molecular Medicine.
  
  He has served as Chair of the Board of
  ...
  Presently, Dr. Caskey serves on the Boards of Essex
  ...
  Dr. Caskey is a member of the Academy of Medicine, Engineering and Science of Texas (President of TAMEST 2004-05), a member of the National Academy of Sciences, and the Institute of Medicine.He serves on Texas Governor Rick Perry's Advisory Committee which provides oversight for the Texas Emerging Technology Fund.He is a
  ...
  Dr. Caskey's most recent award (2007) was the Medical Statesman Award from the Health Access Foundation.

• 
  www.tamest.org/html/news_archive.html - [Cached Version]
  Published on: 2/17/2006    Last Visited: 6/28/2007  

  9/01/2005 - Dr. C. Thomas Caskey appointed to the Texas Emerging Technology Fund Advisory Committee.

• 
  www.instituteofmedicine.org/CMS/3740/10303.aspx - [Cached Version]
  Published on: 9/11/2008    Last Visited: 9/11/2008  

  C. THOMAS CASKEY is Director-Elect and Chief Executive Officer-Elect and Chief Operating Officer of the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), at the University of Texas Health Science Center at Houston.Dr. Caskey was founding director of Houston-based Cogene Biotech Ventures and Cogene Ventures, venture capital funds supporting early-stage biotechnology and life sciences companies.He has received numerous academic and industry-related honors.He is a member of the National Academy of Sciences and the Institute of Medicine.He has served as president of American Society of Human Genetics, the Human Genome Organization and The Academy of Medicine, Engineering and Science of Texas (TAMEST).Dr. Caskey previously served as Senior Vice President for Human Genetics and Vaccines Discovery at Merck Research Laboratories from 1994 to 2000 and as president of the Merck Genome Research Institute from 1998 to 2000.His genetic research documented the universality of the genetic code, discovered the mechanism of peptide chain termination, identified the genetic basis of 10 major heritable diseases, opened the understanding of triplet repeat diseases (Fragile X, myotonic dystrophy and others), developed the STR method of DNA-based personal identification (now used worldwide) for forensic studies, and developed a viral vector vaccine for HIV.He received the Distinguished Texas Geneticist Award from the Texas Genetics Society in 1998 and serves on Texas Governor Rick Perry's Council on Science and Biotechnology, which makes funding recommendations for the $200 million Texas Emerging Technology Fund.Dr. Caskey earned his medical degree from Duke University School of Medicine and his undergraduate degree from the University of South Carolina.He is Board certified in Internal Medicine, Clinical Genetics, Metabolic Diseases and Molecular Diagnostics.

• 
  www.lexpharma.com/news/2000-04-06-170537.html - [Cached Version]
  Published on: 4/6/2000    Last Visited: 6/22/2008  

  THE WOODLANDS, Texas, April 6 /PRNewswire/ -- Lexicon Genetics Incorporated announced today the appointment of C. Thomas Caskey, M.D. as Chairman of its Board of Directors and the election of Sam L. Barker, Ph.D. as a member of its Board of Directors.
  ...
  Dr. Caskey served as Senior Vice President, Research at Merck Research Laboratories from 1995 to March 2000 and as President of the Merck Genome Research Institute from 1996 to March 2000.Before joining Merck, Dr. Caskey served 25 years at Baylor College of Medicine in a series of senior positions, including Chairman, Department of Human and Molecular Genetics and Director, Human Genome Center.He is a member of the National Academy of Sciences and holds numerous other awards and distinctions.Dr. Caskey received his B.A. from the University of South Carolina and his M.D. from Duke University Medical School.

• 
  www.biohouston.org/en/cms/?255 - [Cached Version]
  Published on: 10/6/2008    Last Visited: 6/27/2008  

  C. Tom Caskey, M.D.--President and CEO, Cogene Biotech Ventures

• 
  www.tri-conference.com/08_gbs.asp - [Cached Version]
  Published on: 10/6/2008    Last Visited: 5/11/2008  

  Thomas Caskey, M.D., F.A.C.P., Director and Chief Executive Officer, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center

Page:  1 2 3 4 5